Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies

Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

1999 • 2,474 citations

Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer

1999 • 2,214 citations

Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma

1999 • 1,827 citations

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis

2001 • 1,063 citations

Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer

2001 • 746 citations

HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

2001 • 685 citations

A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results

2001 • 600 citations

Carcinoma of the Anal Canal

2000 • 474 citations

Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy

1995 • 472 citations

Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies

2002 • 456 citations

Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation

2001 • 434 citations

Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies

2000 • 355 citations

Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications

1984 • 315 citations

The Distribution of Active Bone Marrow in the Adult

1961 • 315 citations

Intensity-modulated tangential beam irradiation of the intact breast

1999 • 270 citations

A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group Study

1996 • 239 citations

Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose–volume analysis

2001 • 181 citations

Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy

2003 • 178 citations

Initial Clinical Experience with Intensity-Modulated Whole-Pelvis Radiation Therapy in Women with Gynecologic Malignancies

2001 • 136 citations

Paclitaxel, an Active Agent in Nonsquamous Carcinomas of the Uterine Cervix: A Gynecologic Oncology Group Study

2001 • 111 citations

Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (Ethyol): preclinical aspects.

1994 • 96 citations

Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease

1995 • 94 citations

Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: A dosimetric analysis

1997 • 93 citations

Has the outlook improved for amifostine as a clinical radioprotector?

2000 • 93 citations

The effect of hemoglobin level on radiotherapy outcomes: The Canadian experience

2001 • 77 citations

Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer

1998 • 74 citations

Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer

2002 • 71 citations

First-Line Chemotherapy with Paclitaxel and Platinum for Advanced and Recurrent Cancer of the Cervix—A Phase II Study

1999 • 62 citations

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide

1990 • 60 citations

Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group Phase II Trial of First-Line Irinotecan in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Cervix

1999 • 60 citations

Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy

1995 • 57 citations

Intensity-modulated radiation therapy in gynecologic malignancies

2002 • 52 citations

Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer

1999 • 51 citations

Effect of fractionated regional external beam radiotherapy on peripheral blood cell count

2001 • 49 citations

A Phase II Trial of Prolonged Oral Etoposide (VP-16) as Second-Line Therapy for Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

1996 • 48 citations

Breast-conserving radiation therapy: potential of inverse planning with intensity modulation.

1997 • 47 citations

Treatment Planning at the University of North Carolina at Chapel Hill.

1992 • 43 citations

Treatment planning at the University of North Carolina at Chapel Hill

1992 • 41 citations

Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.

1985 • 31 citations

Cisplatin/5-Fluorouracil Treatment of Recurrent Cervical Carcinoma: A Phase II Study with Long-Term Follow-up

1996 • 28 citations

Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy

2001 • 24 citations

Comparison of IMRT with 3-D CRT for gynecologic malignancies

2001 • 22 citations

Phase II Trial of Mitomycin-C in Squamous Cell Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

1995 • 20 citations

A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix

1990 • 18 citations

Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies

2004 • 16 citations

A STUDT OF THE RELATIVE TOXIC EFFECTS PRODUCED BY REGIONAL RADIATION

1920 • 13 citations

Phase I Trial of Concomitant Vinorelbine, Paclitaxel, and Pelvic Irradiation in Cervical Carcinoma and Other Advanced Pelvic Malignancies

2001 • 12 citations

Phase I Trial of Concomitant Chemoradiotherapy for Cervical Cancer and Other Advanced Pelvic Malignancies

1999 • 11 citations

Conventional 3-D versus intensity modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative study of dose-volume histograms and the potential impact on toxicities

2001 • 10 citations

Clinical experience with Intensity-Modulated Whole Pelvic Radiation Therapy (IM-WPRT) in patients with gynecologic malignancies

2001 • 7 citations

Intensity-modulated radiation therapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiation therapy

2001 • 6 citations

A Phase II Trial of Edatrexate in Previously Treated Squamous Cell Cervical Cancer

1997 • 6 citations